<ul data-eligibleForWebStory="false"><li>ScienceMachine, a British AI startup, raised a €2.9 million pre-Seed funding round to accelerate BioTech data analysis using autonomous AI agents.</li><li>The funding, led by Revent and Nucleus Capital, supports product development, hiring, and aims to help biopharma make discoveries faster and cheaper.</li><li>ScienceMachine's AI agent, Sam, automates data analysis for BioTech organizations, claiming to outpace larger teams 100 times their size.</li><li>Without marketing spend, ScienceMachine is delivering production-level AI automation, reducing costs, accelerating scientific discovery, and expanding its reach into larger companies.</li></ul>

London-based ScienceMachine raises €2.9 million for BioTech analysis with a team of only two and without spending “a cent on marketing”

Discover more